NCT07495735
- Conditions
- Adenocarcinoma, Atezolizumab and Bevacizumab in Hepatocellular Carcinoma, Carcinoma, +10 more
- Locations
-
- First Affiliated Hospital of Wenzhou Medical University Wenzhou, Zhejiang, China
Clinical trial condition
Atezolizumab and Bevacizumab in Hepatocellular Carcinoma
Explore clinical trials studying Atezolizumab and Bevacizumab in Hepatocellular Carcinoma. Study availability and eligibility vary by location and protocol.
3 public trials
1 recruiting study
Atezolizumab and Bevacizumab in Hepatocellular Carcinoma trial results
Enrolling by invitation
Evaluation of Efficacy and Safety of Immune Check Point Inhibitors in Hepatocellular Carcinoma Patients in Ain Shams University Hospitals
NCT07088081
- Conditions
- Adenocarcinoma, Atezolizumab and Bevacizumab in Hepatocellular Carcinoma, Carcinoma, +14 more
- Locations
-
- Ain Shams University Cairo, Abbasya, Egypt
NCT06416683
- Conditions
- Adenocarcinoma, Atezolizumab and Bevacizumab in Hepatocellular Carcinoma, Carcinoma, +9 more
- Locations
-
- CHU de Caen Caen, France/Normandie, France